Volume 86 Issue 36 | p. 21 | Concentrates
Issue Date: September 8, 2008

Sigma-Aldrich To Add High-Potency Plant

Department: Business

Sigma-Aldrich's SAFC Pharma unit will spend $30 million to build a new high-potency active pharmaceutical ingredient (HPAPI) plant in Verona, Wis., near its existing Madison facility. The company says it is purchasing 15 acres on which it will build a 45,000-sq-ft facility with reactors of up to 4,000 L in size. "Currently, there is minimal manufacturing capacity to support market demand for large-scale HPAPI production," says Dave Feldker, vice president of sales and manufacturing for SAFC Pharma. The new plant is expected to be completed by the end of next year.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment